An analysis of the rates of discontinuation and non-publication of colorectal cancer clinical trials

ConclusionWe found that more than one-quarter of trials were prematurely ended, and almost one-third of completed trials did not publish their findings. Subjecting trial participants to potentially harmful treatments and interventions that fail to complete or publish study findings have the potential to undermine the patient-provider relationship, as well as public confidence in government-sponsored clinical trials.
Source: International Journal of Colorectal Disease - Category: Gastroenterology Source Type: research